Search research articles
Contact Us
Filters
Showing results (41-50 of 88) with videos related to
Page
of 9
Sort By:
Epilepsia
|
November 1, 1988
Pharmacology of LY201409, a potent benzamide anticonvulsant
D W Robertson, R R Lawson, R C Rathbun, et al.
Journal of Medicinal Chemistry
|
February 1, 1988
Imidazole-pyridine bioisosterism: comparison of the inotropic activities of pyridine- and imidazole-substituted 6-phenyldihydropyridazinone cardiotonics
D W Robertson, J H Krushinski, G D Pollock, et al.
Journal of Medicinal Chemistry
|
October 29, 1993
Synthesis and anticonvulsant activities of alpha-heterocyclic alpha-acetamido-N-benzylacetamide derivatives
H Kohn, K N Sawhney, P Bardel, et al.
Journal of Cardiovascular Pharmacology
|
April 1, 1987
Pharmacology of LY195115, a potent, orally active cardiotonic with a long duration of action
J S Hayes, G D Pollock, H Wilson, et al.
Life Sciences
|
January 11, 1992
Persistent depletion of striatal dopamine and cortical norepinephrine in mice by 1-methyl-4-phenyl-1,2,3,6-tetrahydro-3-pyridinol (MPTP-3-OL), an analog of MPTP
S K Hemrick-Luecke, D W Robertson, J H Krushinski, et al.
Journal of Medicinal Chemistry
|
August 1, 1991
Preparation and anticonvulsant activity of a series of functionalized alpha-heteroatom-substituted amino acids
H Kohn, K N Sawhney, P LeGall, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 1, 1985
Pharmacology of LY175326: a potent cardiotonic agent with vasodilator activities
J S Hayes, G D Pollock, H Wilson, et al.
Journal of Medicinal Chemistry
|
December 1, 1979
Antiestrogens and antiestrogen metabolites: preparation of tritium-labeled (+/-)-cis-3-[p-(1,2,3,4-tetrahydro-6-methoxy-2-phenyl-1-naphthyl)phenoxyl]-1,2-propanediol (U-23469) and characterization and synthesis of a biologically important metabolite
T Tatee, K E Carlson, J A Katzenellenbogen, et al.
Clinics in Sports Medicine
|
October 1, 1987
Radiographic evaluation of foot and ankle injuries in the athlete
A C Rettig, K D Shelbourne, H F Beltz, et al.
Journal of Receptor and Signal Transduction Research
|
September 1, 1996
Comparison of indolidan analog binding sites of drug antibody and sarcoplasmic reticulum with inhibition of cyclic AMP phosphodiesterase
T Ashikaga, D W Robertson, R J Sportsman, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 88) with videos related to
Sort By:
Page
of 9
Epilepsia
|
November 1, 1988
Pharmacology of LY201409, a potent benzamide anticonvulsant
D W Robertson, R R Lawson, R C Rathbun, et al.
Journal of Medicinal Chemistry
|
February 1, 1988
Imidazole-pyridine bioisosterism: comparison of the inotropic activities of pyridine- and imidazole-substituted 6-phenyldihydropyridazinone cardiotonics
D W Robertson, J H Krushinski, G D Pollock, et al.
Journal of Medicinal Chemistry
|
October 29, 1993
Synthesis and anticonvulsant activities of alpha-heterocyclic alpha-acetamido-N-benzylacetamide derivatives
H Kohn, K N Sawhney, P Bardel, et al.
Journal of Cardiovascular Pharmacology
|
April 1, 1987
Pharmacology of LY195115, a potent, orally active cardiotonic with a long duration of action
J S Hayes, G D Pollock, H Wilson, et al.
Life Sciences
|
January 11, 1992
Persistent depletion of striatal dopamine and cortical norepinephrine in mice by 1-methyl-4-phenyl-1,2,3,6-tetrahydro-3-pyridinol (MPTP-3-OL), an analog of MPTP
S K Hemrick-Luecke, D W Robertson, J H Krushinski, et al.
Journal of Medicinal Chemistry
|
August 1, 1991
Preparation and anticonvulsant activity of a series of functionalized alpha-heteroatom-substituted amino acids
H Kohn, K N Sawhney, P LeGall, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
May 1, 1985
Pharmacology of LY175326: a potent cardiotonic agent with vasodilator activities
J S Hayes, G D Pollock, H Wilson, et al.
Journal of Medicinal Chemistry
|
December 1, 1979
Antiestrogens and antiestrogen metabolites: preparation of tritium-labeled (+/-)-cis-3-[p-(1,2,3,4-tetrahydro-6-methoxy-2-phenyl-1-naphthyl)phenoxyl]-1,2-propanediol (U-23469) and characterization and synthesis of a biologically important metabolite
T Tatee, K E Carlson, J A Katzenellenbogen, et al.
Clinics in Sports Medicine
|
October 1, 1987
Radiographic evaluation of foot and ankle injuries in the athlete
A C Rettig, K D Shelbourne, H F Beltz, et al.
Journal of Receptor and Signal Transduction Research
|
September 1, 1996
Comparison of indolidan analog binding sites of drug antibody and sarcoplasmic reticulum with inhibition of cyclic AMP phosphodiesterase
T Ashikaga, D W Robertson, R J Sportsman, et al.
Page
of 9